DIHS 所致暴发性 1 型糖尿病可能受 HHV-6 再激活影响
该文通过文献检索收集 DIHS 所致暴发性 1 型糖尿病(FT1D)病例,分析 FT1D 发病前后 HHV-6 抗体滴度变化。结果发现全部 8 例在 FT1D 发病前后 HHV-6 抗体滴度升高,其中 1 例在发病前不久检出 HHV-6 DNA。作者认为 HHV-6 再激活与 DIHS 所致 FT1D 发病相关。
要点
- 8 例 DIHS 所致 FT1D 均在发病前后出现 HHV-6 抗体滴度升高。
- 1 例在 FT1D 发病前不久检出 HHV-6 DNA。
- 作者首次提出 HHV-6 再激活与 DIHS 所致 FT1D 发病相关。
核心结论
- 作者认为 HHV-6 再激活与 DIHS 所致 FT1D 发病相关,且为首次提出。
研究设计与样本
- 在既往报道病例基础上,通过文献检索收集 DIHS 所致 FT1D 病例,并分析 FT1D 发病前后 HHV-6 抗体滴度变化。
主要发现
- 全部 8 例在 FT1D 发病前或发病后出现 HHV-6 抗体滴度升高。
- 1 例在 FT1D 发病前不久检出 HHV-6 DNA。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: In the previous issue of this journal, we reported that the incidence of fulminant type 1 diabetes (FT1D) due to the drug-induced hypersensitivity syndrome (DIHS) in Japan is higher than that in the general population and is associated with HLAB62. On the other hand, the reactivation of human herpesvirus 6 (HHV-6), which has been reported to be associated with DIHS, was observed at a higher frequency, but its association with the development of FT1D was unclear. OBJECTIVE: We aimed to clarify the relationship between the onset of FT1D and the reactivation of HHV-6. METHODS: We conducted a literature search for cases of DIHS-induced FT1D in addition to previously reported cases and investigated the changes in the HHV-6 antibody titer before and after the onset of FT1D. RESULTS: The HHV-6 antibody titer was increased just before or after the onset of FT1D in all 8 cases. In 1 case, HHV-6 DNA was also identified shortly before the onset of FT1D. CONCLUSION: These results indicate for the first time that the reactivation of HHV-6 is associated with the onset of FT1D caused by DIHS.
引用
- Makino H, Tohyama M, Kawamura R, et al. Fulminant Type 1 Diabetes Caused by DIHS Could Be Affected by the Reactivation of HHV-6. J Clin Endocrinol Metab. 2024. PMID: 38298135. doi:10.1210/clinem/dgae058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。